Orally administered sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice

被引:11
|
作者
Ono, Kazuhiko [1 ]
Nimura, Satoshi [2 ]
Hideshima, Yuko [1 ]
Nabeshima, Kazuki [2 ]
Nakashima, Manabu [1 ]
机构
[1] Fukuoka Univ, Fac Pharmaceut Sci, Dept Immunol & Mol Pharmacol, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Dept Pathol, Fac Med, Fukuoka 8140180, Japan
关键词
inflammatory bowel disease; ulcerative colitis; inflammation; sodium; 4-phenylbutyrate; oral administration; pro-inflammatory cytokines; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL HOMEOSTASIS; RECEPTOR ANTAGONIST; ULCERATIVE-COLITIS; CROHNS-DISEASE; PATHOGENESIS; THERAPY; PHENYLBUTYRATE; INFLIXIMAB; MANAGEMENT;
D O I
10.3892/etm.2017.5251
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sodium 4-phenylbutyrate (PBA) exerts therapeutic effects in a wide range of pathologies. A previous study by the present authors revealed that intraperitoneal administration of PBA suppresses the onset of dextran sulfate sodium (DSS) -induced colitis in mice. In the present study, the effects of orally administered PBA are investigated, as this route of administration is more clinically relevant. The therapeutic efficacy of PBA (10 mg/12 h) in mice with experimental colitis was assessed based on the disease activity index, production of inflammatory cytokines, colon length and histopathological investigations. The results of the present study demonstrated a significantly higher survival rate in the PBA-treated group compared with the PBA-untreated (DSS control) group (P=0.0156). PBA treatment improved pathological indices of experimental colitis (P<0.05). Furthermore, the oral administration of PBA significantly inhibited the DSS-induced shortening of the colon (P<0.05) and overproduction of interleukin (IL)-1 beta and IL-6 (both P<0.05) as measured in colonic lavage fluids. A marked attenuation of the DSS-induced overproduction of tumor necrosis factor was also observed. For histopathological analysis, a marked decrease in mature goblet cells and increase in enlarged nuclei of the absorptive cells was observed in colon lesions of DSS control mice as compared with normal untreated mice. However, in the PBA-treated mice, no such lesions were observed and the mucosa resembled that of DSS-untreated mice. The results of the present study, combined with those results of a previous study, suggest that oral and intraperitoneal administration of PBA have similar preventative effects on DSS-induced colitis, achieved by suppressing its pathogenesis.
引用
收藏
页码:5485 / 5490
页数:6
相关论文
共 50 条
  • [1] Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium- induced colitis in mice
    Ono, Kazuhiko
    Nimura, Satoshi
    Nishinakagawa, Takuya
    Hideshima, Yuko
    Enjyoji, Munechika
    Nabeshima, Kazuki
    Nakashima, Manabu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (03) : 573 - 578
  • [2] Curcumin and resveratrol suppress dextran sulfate sodium-induced colitis in mice
    Zhang, Lize
    Xue, Hui
    Zhao, Gang
    Qiao, Cuixia
    Sun, Xiaomei
    Pang, Chengjian
    Zhang, Dianliang
    MOLECULAR MEDICINE REPORTS, 2019, 19 (04) : 3053 - 3060
  • [3] Bortezomib protects against dextran sulfate sodium-induced ulcerative colitis in mice
    Hu, Li-Hong
    Fan, Yu-Jing
    Li, Qing
    Guan, Jing-Ming
    Qu, Bo
    Pei, Feng-Hua
    Liu, Bing-Rong
    MOLECULAR MEDICINE REPORTS, 2017, 15 (06) : 4093 - 4099
  • [4] Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice
    da Silva, Andre Paes Batista
    Ellen, Richard P.
    Sorensen, Esben S.
    Goldberg, Harvey A.
    Zohar, Ron
    Sodek, Jaro
    LABORATORY INVESTIGATION, 2009, 89 (10) : 1169 - 1181
  • [5] Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis
    Jeong, Eui Man
    Son, Young Hoon
    Choi, Yewon
    Kim, Jin-Hee
    Lee, Jin-Haeng
    Cho, Sung-Yup
    Kim, In-Gyu
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2016, 48 : e267 - e267
  • [6] Phototherapy with artificial light suppresses dextran sulfate sodium-induced colitis in a mouse model
    Hiratsuka, Takahiro
    Inomata, Masafumi
    Goto, Shigeru
    Oyama, Yoshimasa
    Nakano, Toshiaki
    Chen, Chao-Long
    Shiraishi, Norio
    Noguchi, Takayuki
    Kitano, Seigo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (04) : 749 - 756
  • [7] Anti-inflammatory effect of Euphorbia supina extract in dextran sulfate sodium-induced colitis mice
    Cha, Ji-Yun
    Jeon, Yong-Deok
    Xin, Mingjie
    Kim, Do-Kuk
    Lee, Hoon-Yeon
    Kim, Bo-Ram
    Hwang, Sung-Woo
    Kim, Dae-Ki
    Jin, Jong-Sik
    Lee, Young-Mi
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2017, 81 (11) : 2178 - 2185
  • [8] Pingwei San ameliorates dextran sulfate sodium-induced chronic colitis in mice
    Zhang, Zecai
    Shen, Peng
    Xie, Wenbing
    Cao, Hongyang
    Liu, Jiuxi
    Cao, Yongguo
    Zhang, Naisheng
    JOURNAL OF ETHNOPHARMACOLOGY, 2019, 236 : 91 - 99
  • [9] The potential mechanism of Bawei Xileisan in the treatment of dextran sulfate sodium-induced ulcerative colitis in mice
    Wen, Juan
    Teng, Baoxia
    Yang, Pingrong
    Chen, Xinjun
    Li, Chenhui
    Jing, Yaping
    Wei, Junshu
    Zhang, Chunjiang
    JOURNAL OF ETHNOPHARMACOLOGY, 2016, 188 : 31 - 38
  • [10] Antioxidant and anti-inflammatory effect of plumieride in dextran sulfate sodium-induced colitis in mice
    Boeing, Thaise
    de Souza, Priscila
    Bonomini, Tiago Jose
    Bolda Mariano, Luisa Nathalia
    Somensi, Lincon Bordignon
    Lucinda, Ruth Meri
    Malheiros, Angela
    da Silva, Luisa Mota
    de Andrade, Sergio Faloni
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 99 : 697 - 703